Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes

Autor: Giovanni Targher, Fabrice Bonnet, Giuseppe Lippi, Alessandro Mantovani, Stefano Bonapace, Anna Altomari, Gianluigi Lunardi

Publikováno v: Diabetes & Metabolism. 46:326-330

Aim Emerging evidence suggests that specific plasma ceramides are involved in the pathophysiology of cardiovascular disease (CVD) and other inflammation-associated diseases. However, scarce information is currently available on the association betwee

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6d88cad1662896a6e3fcc521c22ca5e
https://doi.org/10.1016/j.diabet.2019.05.008

Impact of bariatric surgery-induced weight loss on circulating PCSK9 levels in obese patients

Autor: Albino Eccher, Marta Aventaggiato, Anna Altomari, Nicola Ferri, M. G. Zenti, Enzo Bonora, Giovanni Targher, Elena Paiola, Serena Galvan, Damiano Sandri, Massimiliano Ruscica, Maria Giovanna Lupo, Marco Battistoni, Chiara Maneschi, Sara De Martin

Background and aims To investigate the effect of obesity and bariatric-induced weight loss on circulating levels of proprotein convertase subtilisin/kexin 9 (PCSK9) in severely obese patients. Methods and results In this non-randomized interventional

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e95bb574d21ddec0b09ab3d65dd60c57
http://hdl.handle.net/11562/1030484

Association between helicobacter pylori infection and risk of nonalcoholic fatty liver disease: an updated meta-analysis

Autor: Luca Valenti, Herbert Tilg, Alessandro Mantovani, Amedeo Lonardo, Anna Altomari, Giovanni Targher, Teresa Turino, Giacomo Zoppini, Christopher D. Byrne

Background Recent studies that have examined the association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease (NAFLD) have produced conflicting data. We have performed a systematic review and meta-analysis to assess

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76ace224b1a2029f0f924fc9c00bea06
https://eprints.soton.ac.uk/430416/

Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease

Autor: Clementina Dugo, Fabrice Bonnet, Reijo Laaksonen, Giovanni Targher, Giulio Molon, Alessandro Mantovani, C. Bovo, Gianluigi Lunardi, Stefano Bonapace, Anna Altomari, A. Conti, Christopher D. Byrne

Publikováno v: Diabetes and Metabolism
Diabetes and Metabolism, Elsevier Masson, 2020, ⟨10.1016/j.diabet.2020.03.003⟩
Diabetes & Metabolism
Diabetes & Metabolism, Elsevier Masson, 2020, ⟨10.1016/j.diabet.2020.03.003⟩

Aim Plasma levels of certain ceramides are increased in patients with ischemic heart disease (IHD). Many risk factors for IHD are also risk factors for chronic kidney disease (CKD), but it is currently uncertain whether plasma ceramide levels are inc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d482691daee5832f8879e43e60af71df
https://doi.org/10.1016/j.diabet.2020.03.003

Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case report

Autor: Anna Altomari, M. G. Zenti, Claudia Stefanutti, Marco Dauriz, A. Fabris, Enzo Bonora, V. Sanga

A 49 years old woman (weight 68 kg, BMI 27.3 kg/m2 ) with heterozygous familial hypercholesterolemia (HeFH) and multiple statin intolerance with muscle aches and creatine kinase elevation, presented at the Outpatient Lipid Clinic of Verona University

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7adee79852b4aaa4f3693beb6aef3f4
http://hdl.handle.net/11573/1504579